1. Home
  2. IVVD vs IMMR Comparison

IVVD vs IMMR Comparison

Compare IVVD & IMMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Invivyd Inc.

IVVD

Invivyd Inc.

HOLD

Current Price

$0.82

Market Cap

219.9M

Sector

Health Care

ML Signal

HOLD

Logo Immersion Corporation

IMMR

Immersion Corporation

HOLD

Current Price

$7.25

Market Cap

215.8M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
IVVD
IMMR
Founded
2020
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer peripheral equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
219.9M
215.8M
IPO Year
2021
1999

Fundamental Metrics

Financial Performance
Metric
IVVD
IMMR
Price
$0.82
$7.25
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
1
Target Price
$8.75
★ $13.50
AVG Volume (30 Days)
★ 4.9M
308.4K
Earning Date
05-08-2026
04-13-2026
Dividend Yield
N/A
★ 5.11%
EPS Growth
★ 79.02
N/A
EPS
N/A
★ 0.17
Revenue
★ $53,426,000.00
$35,013,000.00
Revenue This Year
$61.57
N/A
Revenue Next Year
$41.42
N/A
P/E Ratio
★ N/A
$42.65
Revenue Growth
★ 110.47
N/A
52 Week Low
$0.53
$5.25
52 Week High
$3.07
$8.05

Technical Indicators

Market Signals
Indicator
IVVD
IMMR
Relative Strength Index (RSI) 47.06 45.38
Support Level $0.72 $6.30
Resistance Level $1.02 $7.76
Average True Range (ATR) 0.09 0.18
MACD 0.00 -0.02
Stochastic Oscillator 28.19 36.04

Price Performance

Historical Comparison
IVVD
IMMR

About IVVD Invivyd Inc.

Invivyd Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of monoclonal antibody (mAb) therapies for the prevention and treatment of serious viral infectious diseases. Its lead product, PEMGARDA (pemivibart), received emergency use authorization from the U.S. FDA for the pre-exposure prevention of COVID-19 in certain immunocompromised individuals. The company is also developing next-generation antibody candidates, including VYD2311 for COVID-19 and VBY329 for RSV infections, while continuing research on additional antibodies targeting other viral diseases such as measles.

About IMMR Immersion Corporation

Immersion Corp is focused on the creation, design, development, and licensing of haptic technologies that allow people to use its sense of touch more fully as it involves engaging with products and experience the digital world. The company's software focuses on applications in mobile devices, wearables, consumer, and gaming devices markets. It generates revenue from royalty and license fees, and development contract and service fees. Geographically, the company generates a majority of its revenue from Japan, followed by Korea, Germany, United States of America and other countries.

Share on Social Networks: